Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper
The work of Lebrun et al now adds an important piece to this puzzle by describing a critical and previously unrecognized role for the gut-derived hormone glucagon-like-peptide 1 (GLP-1) in the regulation of intestinal inflammation
Benefits of GLP-1 and related therapies When prescribed and monitored by a doctor, these medicines may help patients achieve: Significant weight loss Improved blood-sugar control Reduced cardiovascular risk Lower blood pressure in some patients Improved metabolic health GLP-1 receptor agonists are already widely used for type 2 diabetes and weight management, and ongoing research suggests they may have benefits beyond these conditions
We also finalized to gradually increase the number of quarters of data hospitals would be required to report on the measure ( starting with two self-selected quarters for the CY 2027 reporting period/CY 2029 payment determination, and all four quarters for the CY 2028 reporting period/CY 2030 payment determination (88 FR 82134)
This is because better blood sugar control and weight loss can lead to fewer symptoms of type 2 diabetes, such as fatigue and frequent urination
Select the level of service for these E/M codes based solely on the medical decision making or the physician time dedicated to the encounter
